27 /100
MEDIUM RISK
Score updated May 30, 2026

KLRS — Kalaris Therapeutics, Inc. Dilution Risk Tracker

Track KLRS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KLRS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
65
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for KLRS.
🔔 Track KLRS — Get forecast alerts →

💹 Market Data

Market Cap$125.39M
Shares Outstanding23.79M
Float6.57M
Cash$97.22M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 37.0% shares (2025Q4 vs prior)
51 institutional holders · 18.11M shares
#1 SAMSARA BIOCAPITAL, LLC 12.95M shares
#2 RTW INVESTMENTS, LP 1.30M shares
#3 Paradigm Biocapital Advisors LP 700.0K shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest804.4K
Days to Cover7.9
% of Float12.2%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
4 INSIDER TRANSACTION Feb 17, 2026
4 INSIDER TRANSACTION Dec 22, 2025
8-K 8K EVENT Dec 18, 2025
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track KLRS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KLRS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for KLRS
📊 KLRS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 KLRS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.